Article
HER2-Mutant Advanced and/or Metastatic Non-Small-Cell Lung Cancer: A US Electronic Health Records Database Analysis of Clinical Characteristics, Treatment Practice Patterns, and Outcomes.
Clinical lung cancer - 1 Jun 2024
Waliany Sarah, Neal Joel W, Engel-Nitz Nicole, Lam Clara, Lin Feng, Park Leah, Le Lisa, Nagasaka Misako
Abstract excerpt
BACKGROUND: Real-world data for advanced/metastatic non-small-cell lung cancer (NSCLC) with mutations in human epidermal growth factor 2 (HER2) are scarce. We aimed to assess treatment patterns and outcomes among patients with HER2-mutant advanced/metastatic NSCLC. PATIENTS AND METHODS: This retrospective nationwide electronic health record study evaluated patient characteristics, treatment patterns, treatment...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.